Current location - Health Preservation Learning Network - Healthy weight loss - The inactivated vaccine made in COVID-19 is expected to be available at the end of February. Is it expensive?
The inactivated vaccine made in COVID-19 is expected to be available at the end of February. Is it expensive?
The large-scale outbreak of the epidemic in 2020 worried everyone. With the gradual improvement of the epidemic situation, good news about the epidemic situation came one after another, and the news about COVID-19 epidemic vaccine has always been the focus of people's attention. At present, there is news on the Internet that it costs 1000 yuan or more to get a vaccine in COVID-19. There are even rumors that WeChat merchants openly sell a COVID-19 vaccine for several hundred yuan. Although all these news proved to be false rumors in the end, Liu Jingzhen, the chairman of China Pharmaceutical Group, revealed the price range of COVID-19 vaccine after its listing in the future when interviewed by reporters and friends. He said that the price of COVID-19 vaccine will not be too high after it goes on the market. It is estimated that the price of one needle is several hundred yuan, and the price of two needles is controlled within 1000 yuan.

Regarding the price of COVID-19 vaccine circulating on the Internet of 1,000 yuan, many experts said that the high price may affect the popularization of vaccine in COVID-19. Tao Lina, a vaccine expert, thinks that if the price of vaccines in COVID-19 is too expensive, it will affect the accessibility. If the vaccination rate of COVID-19 vaccine does not reach a certain level, there is no way to achieve large-scale mass immunization. If this virus is introduced, it will cause a small-scale epidemic.

At present, the most expensive domestic vaccine, pneumonia vaccine, actually belongs to 13 pneumonia vaccine. At present, the bidding price is 598 yuan, and all other expenses add up to about 25 yuan. At present, COVID-19 vaccine is still in the third phase of clinical trial and has not been listed, so its pricing range can only be evaluated after it is listed.

The epidemic also exposed the country's shortcomings in security issues, and experts suggested that security issues should be included in the national reserve. Vigorously support the work of various vaccine research and development enterprises and promote the progress of national medical and health safety. At the same time, we should also strengthen and improve the biosafety system of the whole country. Popularize biological safety knowledge to ensure the safety of people's lives and property.